Internal Medicine, Nephrology · Bellmore, NY
NPI
1740264969
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
250 Pettit Ave, Ste 4
Bellmore, NY, 11710
Phone (516) 409-0106
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
8,526 services
Medicare patients, 2024
291
Average age 75
Drug cost, 2024
$1.1M
2,058 prescriptions
Company payments, 2025
$2,172
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gregory P Dilimetin was code J1756 (injection, iron sucrose, 1 mg), 2,800 times for 11 patients. In total Gregory P Dilimetin billed 8,526 services in 56 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 2,800 | 11 | $0.17 | $477 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 740 | 13 | $5.86 | $4,336 |
| 99232 Hospital E&M - Subsequent | Facility | 577 | 104 | $69.33 | $40K |
| 99214 Office E&M - Established | Office | 279 | 123 | $67.94 | $19K |
| 36415 Venipuncture Blood Collection | Office | 217 | 88 | $8.65 | $1,877 |
| 80053 Clinical Chemistry | Office | 179 | 73 | $10.35 | $1,853 |
| 83036 Blood Count | Office | 168 | 70 | $9.52 | $1,599 |
| 83970 Clinical Chemistry | Office | 166 | 70 | $40.45 | $6,715 |
| 83540 Clinical Chemistry | Office | 166 | 71 | $6.34 | $1,052 |
| 82728 Clinical Chemistry | Office | 165 | 71 | $13.36 | $2,204 |
| 83550 Clinical Chemistry | Office | 165 | 70 | $8.57 | $1,414 |
| 82306 Clinical Chemistry | Office | 164 | 69 | $29.01 | $4,758 |
| 85025 Blood Count | Office | 161 | 69 | $7.61 | $1,225 |
| 90960 ESRD Related Services (not dialysis) | Office | 161 | 42 | $294.84 | $47K |
| 83735 Clinical Chemistry | Office | 159 | 68 | $6.57 | $1,045 |
By year: 2022 $309K for 19,021 services; 2023 $214K for 17,226 services; 2024 $193K for 8,526 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 217 | 88 | $8.65 | $1,877 |
| 80053 Clinical Chemistry | 179 | 73 | $10.35 | $1,853 |
| 83036 Blood Count | 168 | 70 | $9.52 | $1,599 |
| 83540 Clinical Chemistry | 166 | 71 | $6.34 | $1,052 |
| 83970 Clinical Chemistry | 166 | 70 | $40.45 | $6,715 |
| 82728 Clinical Chemistry | 165 | 71 | $13.36 | $2,204 |
| 83550 Clinical Chemistry | 165 | 70 | $8.57 | $1,414 |
| 82306 Clinical Chemistry | 164 | 69 | $29.01 | $4,758 |
| 85025 Blood Count | 161 | 69 | $7.61 | $1,225 |
| 83735 Clinical Chemistry | 159 | 68 | $6.57 | $1,045 |
Medicare prescription drug claims, 2024
In 2024, the drug Gregory P Dilimetin prescribed most often to Medicare patients was Losartan Potassium, with 161 prescriptions and refills. In total Gregory P Dilimetin wrote 2,058 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Losartan Potassium Generic | 161 | 469 | 48 | $1,347 |
| Rosuvastatin Calcium Generic | 123 | 367 | 40 | $1,071 |
| Calcitriol Generic | 108 | 286 | 31 | $1,937 |
| Ozempic Semaglutide | 100 | 198 | 27 | $186K |
| Lokelma Sodium Zirconium Cyclosilicate | 72 | 121 | 18 | $105K |
| Hydralazine Hcl Generic | 67 | 189 | 22 | $826 |
| Allopurinol Generic | 66 | 186 | 20 | $383 |
| Cinacalcet Hcl Generic | 57 | 103 | 13 | $55K |
| Atorvastatin Calcium Generic | 55 | 131 | 17 | $332 |
| Nifedipine Er Nifedipine | 51 | 146 | 17 | $3,217 |
| Amlodipine Besylate Generic | 50 | 126 | 19 | $149 |
| Lisinopril Generic | 47 | 143 | 16 | $226 |
| Kerendia Finerenone | 46 | 100 | 13 | $63K |
| Paricalcitol Generic | 45 | 131 | 16 | $5,427 |
| Tamsulosin Hcl Generic | 41 | 114 | 12 | $660 |
Brand drugs: 420 claims; generic drugs: 1,638 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gregory P Dilimetin $2,172 ($2,172 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novo Nordisk Inc with $346.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 15 | $346 |
| Mallinckrodt Hospital Products Inc. | 13 | $338 |
| Amgen Inc. AMGN | 13 | $278 |
| OPKO Pharmaceuticals, LLC | 12 | $212 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $112 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $110 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $104 |
| Travere Therapeutics, Inc. TVTX | 4 | $86.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.